Amyris, Inc. (Emeryville, Calif.), a vertically integrated biomanufacturing company, said it will acquire Oobli Inc. (Davis, Calif.), a specialist in fermentation-based sweet proteins that food and beverage brands use to reduce sugar without sacrificing taste.
Amyris said the transaction is expected to close in the coming weeks, and that all of Oobli's existing customer commitments and brand partnerships will continue to be honored without interruption.
Combining science and fermentation expertise
According to Amyris, the acquisition pairs its scientific capabilities and manufacturing depth with Oobli's protein fermentation know-how. The move follows Amyris' expansion earlier this year of manufacturing capacity at its advanced fermentation facility in Barra Bonita, Brazil. Amyris described the deal as a strategic commercial and technology expansion that accelerates its presence in protein- and peptide-based solutions across end markets.
"In Oobli, we see a commercial and technology platform that is a great complement to our own," Amyris chief executive officer Kathy Fortmann said in a statement. She said Oobli is positioned to change how sweetness reaches the market, and that Amyris aims to add its commercial scale and resources to accelerate that effort.
Fortmann said that combining Oobli's protein expertise with Amyris' strain engineering, manufacturing scale and commercial capabilities could broaden its reach in food and beverage, personal care, flavor and fragrance, agriculture and other markets.
Sweet protein portfolio
Oobli's commercial portfolio of sweet proteins will be the first to benefit from the combined platform. The company has spent the past decade refining a fermentation process to produce sweet proteins found naturally in rare fruits and berries grown near the equator.
Amyris said sweet proteins are the first of their kind in the sugar-reduction category. They are hundreds to thousands of times sweeter than sugar, bind directly to sweet taste receptors and are metabolized by the body as protein, delivering sweetness without gut disruption or blood sugar spikes, the company said.
The portfolio includes Oubli Fruit, Serendipity Berry and Katemfe Fruit Sweet Proteins, known scientifically as brazzein, monellin and thaumatin. Amyris said the ingredients hold FDA GRAS status as an ingredient and are FEMA GRAS-affirmed for use as a natural flavor.
With growing consumer attention to metabolic health and sugar reduction, Amyris said sweet proteins give brands a tool to lower sugar across categories including sports and nutrition, dairy, beverages, chocolate, bakery and confectionery.
Oobli chief executive officer Ali Wing said the company had long believed there was a better way to deliver the sweet taste consumers want without trade-offs to health and the environment, and that joining Amyris would provide the scale and resources to pursue its ambition of making sweet proteins a global standard. "Sweet proteins are an idea whose time is now," Wing said.
Fortmann added that Amyris has observed that biomanufactured solutions succeed when they align with consumer demand and market needs, and that Oobli's platform lets brands address sweet taste, sugar reduction and clean label together. "We could not be more excited to welcome the Oobli team into the Amyris family," she said.
